Alan E. Moormann
G. D. Searle & Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alan E. Moormann.
Synthetic Communications | 1993
Alan E. Moormann
Abstract Borane-pyridine complex (BAP) was found to be an excellent replacement for NaCNBH3 in the Borch reduction. Assorted aromatic, heterocyclic and aliphatic aldehydes were reacted with various substituted piperidines using standardized conditions.
Tetrahedron Letters | 1988
Daniel L. Zabrowski; Alan E. Moormann; Kenneth R. Beck
Abstract The oxidation of aromatic amines to the corresponding nitro substituents is performed under mild, nonacidic conditions in the presence of highly nucleophilic aromatic systems such as indoles and furans.
Bioorganic & Medicinal Chemistry Letters | 2001
Alan E. Moormann; Sue Metz; Mihaly V. Toth; William M. Moore; Gina M. Jerome; Christine M. Kornmeier; Pamela T. Manning; Donald W. Hansen; Barnett S. Pitzele; Ronald Keith Webber
The potency and selectivity of a series of 5-hetero-2-iminohexahydroazepines were examined as inhibitors of the three human NOS isoforms. The effect of ring substitution of the 5-carbon for a heteroatom is presented. Potencies (IC(50)s) for these inhibitors are in the low micromolar range for hi-NOS with some examples exhibiting a 500x selectivity versus hec-NOS.
Tetrahedron Letters | 1999
Daniel P. Becker; Robert K. Husa; Alan E. Moormann; Clara I. Villamil
Abstract A racemic synthesis of azanoradamantane (±) -3 was accomplished via Yamamotos MAD-catalyzed Diels-Alder protocol. Subsequently, a scalable asymmetric synthesis of azanoradamantane benzamide SC-52491 was carried out employing Helmchens asymmetric Diels-Alder methodology to construct all four contiguous asymmetric centers with the correct relative stereochemistry and in 99.3% e.e.
Tetrahedron | 1999
Daniel P. Becker; Robert K. Husa; Alan E. Moormann; Clara I. Villamil; Daniel L. Flynn
Abstract A racemic synthesis of azanoradamantane (±) -3 was accomplished via Yamamotos MAD-catalyzed Diels-Alder protocol. Subsequently, a scalable asymmetric synthesis of azanoradamantane benzamide SC-52491 was carried out employing Helmchens asymmetric Diels-Alder methodology to construct all four contiguous asymmetric centers with the correct relative stereochemistry and in 99.3% e.e.
Synthetic Communications | 1987
Alan E. Moormann; Chung H. Yen; Stella S. Yu
Abstract A synthesis of 2-aminonicotinaldehyde (1) which does not require chromatography and is easily scaled up has been developed. Bromination of 2-amino-3-picoline, protected as a phthalimide (4), produced the gem-dibromide (5), which was reacted with Nh4OH. The imine intermediate (7) was hydrolyzed with acid, producing (1) in a 56% conversion from 4.
Pharmacochemistry Library | 1996
Daniel P. Beckers; Bella Goldstin; Gary W. Gullikson; Richard Loeffler; Alan E. Moormann; Chaffiq Moummi; Roger Nosal; Dale P. Spangler; Clara I. Villamil; Dai-C. Yang; Daniel L. Zabrowski; Daniel L. Flynn
Publisher Summary This chapter discusses the design and synthesis of agonists and antagonists of the serotonin 5-HT4 receptor subtype. Serotonin is unsurpassed among monoamine neurotransmitters in the number of receptor subtypes reported to-date. Fourteen subtypes of seven major serotonin receptor classes have been identified in the central nervous system, the peripheral nervous system, myeloid/immune cell types, and smooth musculature of mammals. For some time, it has been known that serotonin exerts profound effects in the enteric nervous system (ENS). It has been previously appreciated that 5-HT4 agonism requires a planar orientation of the amide bond and the aromatic ring system. This feature contributes to the potent agonist properties of the ortho-alkoxy benzamides i, wherein intramolecular hydrogen-bonding maintains such a planar conformation.
Archive | 1995
Alan E. Moormann; Daniel P. Becker; Daniel L. Flynn; Hui Li; Clara I. Villamil
Archive | 1995
Daniel P. Becker; Daniel L. Flynn; Alan E. Moormann; Roger Nosal; Clara I. Villamil
Journal of Medicinal Chemistry | 2006
Daniel P. Becker; Daniel L. Flynn; Alan E. Moormann; Roger Nosal; Clara I. Villamil; Richard Loeffler; Gary W. Gullikson; Chafiq Moummi; Dai-C. Yang